US FDA May Play Central Role In Assuring Access To Mifepristone Post Roe v. Wade

HHS will take steps to increase access to abortion medication and prevent states from banning it, Secretary Becerra says, but also is questioned about whether the FDA can speed up certification of pharmacies and if the Justice Department would sue states banning access.

abortion pill
The Biden Administration vowed to protect access to the abortion pill. • Source: Shutterstock

The Biden Administration plans to increase access to the abortion pill Mifeprex (mifepristone) as a way to lessen the devastating impact of the US Supreme Court’s overturning Roe v. Wade. While it has presented no specifics on how it will do so, the US Food and Drug Administration could have a significant role in the endeavor.

Health and Human Services Secretary Xavier Becerra announced at a 28 June press briefing that ensuring access to medication abortion...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Compliance

More from Pink Sheet